Clinical studies have demonstrated that Ozempic offers a substantial potential for weight lossoften surpassing other GLP-1 medications
2019 ACC/AHA Guideline on the primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines
Notably, with a significant 29% risk reduction when looking at three or more years exposure to GLP-1RA. They added, Our sensitivity analysis supported the finding of risk reduction when looking at users of GLP-1RA. These findings support the possibility of GLP-1RA being an adjunctive therapy to IOP-reducing eye drops in glaucoma management, the authors argue
Alteration of GLP-1/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin
Retatrutide is an investigational medicine being developed by Eli Lilly as a potential treatment for obesity and type 2 diabetes
Related lab tests: Hemoglobin A1C, Glucose, Comprehensive Metabolic Panel, Kidney Profile, Lipid Panel, Lipase, Amylase, Hepatic Function Panel with GGT, CBC, Ferritin, Iron and TIBC, Vitamin B12, Folate, and Vitamin D
